After @ weeks of rosuvastatin , we found significant decreases in plasma levels of soluble CD@ ( -@ % vs @ % , P = @ ) and in proportions of tissue factor-positive patrolling ( CD@ ( Dim ) CD@ ( + ) ) monocytes ( -@ % vs -@ % , P = @ ) in rosuvastatin-treated vs placebo-treated subjects .